Product Information
PINDOLOL 5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.5969 per EA under NDC 76385013101. Its NADAC has been published 338 times since Mar 11, 2020.
FDA first approved this application on Aug 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
76385013101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PINDOLOLApproval Type
Generic (ANDA)
FDA Application
ANDA211712FDA Approved
8/1/2019
TE Code
AB
On Market Since
2/1/2020
Pharmacological Classes
Price Statistics
The NADAC for PINDOLOL 5 MG TABLET has been published 338 times since Mar 11, 2020, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5969 per EA |
|---|---|
| All-time high | $0.9064 (Dec 15, 2021) |
| All-time low | $0.3653 (May 22, 2024) |
| 52-week high | $0.7057 |
| 52-week low | $0.5224 |
| Median price | $0.7609 |
| Average price | $0.7330 |
| Largest weekly change | -39.6% (May 22, 2024) |
| Weeks tracked | 338 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pindolol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pindolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PINDOLOL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PINDOLOL 5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.5969 per EA (NDC 76385013101), effective Sep 30, 2026.
How has the price of PINDOLOL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PINDOLOL 5 MG TABLET has declined 22.7%. It has been tracked across 338 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for PINDOLOL 5 MG TABLET?
Since Mar 11, 2020, the NADAC for PINDOLOL 5 MG TABLET has ranged from a low of $0.3653 (May 22, 2024) to a high of $0.9064 (Dec 15, 2021), with a median of $0.7609 per EA.
Are there cheaper alternatives to PINDOLOL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PINDOLOL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PINDOLOL 5 MG TABLET?
PINDOLOL 5 MG TABLET (NDC 76385013101) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.